Methotrexate Ebewe

Methotrexate, the active ingredient in Methotrexate Ebewe, is an antimetabolite presented as an injectable solution for intramuscular and intravenous use. It is employed to treat autoimmune disorders such as rheumatoid arthritis and psoriasis, as well as several malignancies including acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease.

GNH USA supplies Methotrexate Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide, with established distribution networks that meet regulatory requirements across EU and other markets globally.

Methotrexate is an antimetabolite used in autoimmune and oncologic disease pathways.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell proliferation and plaque formation. - Acute lymphoblastic leukemia: interferes with malignant cell replication. - Osteosarcoma: limits tumor growth by blocking DNA synthesis. - Gestational trophoblastic disease: induces remission by targeting rapidly dividing trophoblastic tissue.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: persistent tiredness affecting daily activities. - Mouth sores: ulceration of oral mucosa. - Low blood cell counts: reduced white cells, red cells, or platelets. - Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects: - Severe infection: opportunistic infections due to immunosuppression. - Pulmonary toxicity: interstitial pneumonitis or fibrosis. - Liver fibrosis or cirrhosis: progressive hepatic injury. - Bone marrow failure: aplastic anemia or pancytopenia. - Renal toxicity: impaired kidney function with high doses.

Careful monitoring and patient education are essential when using methotrexate.

- Monitor blood counts: perform regular CBC to detect cytopenias. - Assess liver function: periodic LFTs to identify hepatotoxicity. - Evaluate renal function: check creatinine clearance before dosing. - Avoid use in pregnancy: teratogenic risk requires effective contraception. - Counsel on infection risk: advise prompt reporting of fever or signs of infection. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Methotrexate may interact with several drug classes, requiring dose adjustments or avoidance.

Major Interactions (Avoid): - NSAIDs: increase methotrexate toxicity by reducing renal clearance. - Trimethoprim‑sulfamethoxazole: potentiate myelosuppression. - Live vaccines: heightened risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppressive effect. - Penicillins: may reduce methotrexate elimination. - High‑dose vitamin C: can increase renal clearance and alter exposure.